Novartis Bioventures Ltd 13D/13G Filings for Annexon, Inc. (ANNX)

Novartis Bioventures Ltd 13D and 13G filings for Annexon, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-11
4:30 pm
Sale
2021-12-3113GANNEXON INC
ANNX
Novartis Bioventures Ltd910,747
2.370%
-1,196,497decrease
(-56.78%)
Filing